Saakshi Medtech and Panels Limited is a high-precision engineering and manufacturing powerhouse based in India. The company has evolved from a specialized control panel manufacturer into a diversified provider of **High-Level Assemblies (HLA)** and integrated solutions. Serving global **Original Equipment Manufacturers (OEMs)**, the company operates at the intersection of critical infrastructure sectors, including **Medical Technology, Renewable Energy, Electric Mobility, Aerospace, and Defense**. --- ### **Core Manufacturing Verticals & Product Ecosystem** The company’s operations are structured into four primary divisions, supported by a strategy of **backward integration** to ensure quality control and margin protection. * **Integrated Control Systems & EV Solutions:** This is the company’s largest revenue driver (**~57-58%** of mix). It designs and assembles sophisticated cabinets using **PLCs, SCADA, and micro-controllers**. Applications span elevators, air compressors, and renewable energy. Notably, this vertical now includes **EV Charging Infrastructure**. * **Engineered Metal Assemblies (Locomotives & Infrastructure):** Specializing in complex fabrication for the transportation sector, producing **sensor boxes, battery boxes, dynamic brake weldments, and snow plows**. It serves as a critical partner to **Wabtec** under a long-term agreement valid through **2027**. * **Medical X-Ray Systems:** A full-stack provider of X-ray machines, imaging systems, and generators. The company is one of the few in its tier holding both **AERB** and **CDSCO** licenses, alongside **ISO 13485:2016** certification. * **Wire Harness Division:** Primarily focused on **captive consumption**, this unit manufactures specialized cable assemblies for the medical and electrical divisions, ensuring seamless signal transmission in complex electronic environments. --- ### **Strategic Pivot: High-Margin Growth Frontiers** Saakshi Medtech is aggressively diversifying into high-entry-barrier sectors to de-risk its portfolio and enhance profitability. * **Electric Vehicle (EV) Infrastructure:** The company secured a landmark **₹250 crore** Letter of Business Award (LoBA) from **Mahindra & Mahindra** for EV panel supply through **2029**. In **Q1 FY26**, this segment generated **₹24.09 crore**, surpassing the total EV revenue for the entire previous fiscal year. * **Aerospace & Defense:** Leveraging its **AS9100D certification**, the company is transitioning defense into a mainstream vertical. It recently registered as a vendor for a **leading Indian industrial conglomerate** (Feb 2026). Revenue in aviation grew **7-fold** in **H1 FY26** compared to the previous year, with a long-term target of contributing **20%** to total revenue. * **Renewable Energy (Wind):** Partnered with a leading group to develop India’s largest wind turbine. While the **GE spin-off** caused temporary deferments, the company is establishing a dedicated wind manufacturing facility to resume serial production by **late 2025**. * **Precision Radiators:** Successful productionization of radiators for **Rolls-Royce** (44 DG sets for data centers) marks an entry into high-spec thermal management. --- ### **Operational Infrastructure & Scalability** The company is currently executing a phased transition from rented premises to a consolidated, owned manufacturing base in **Pune, Maharashtra**. | Infrastructure Metric | Current Status / Phase 1 | Phase 2 / Long-term Target | | :--- | :--- | :--- | | **Total Facility Area** | **9,600 sq. meters** (3 Units) | **130,000 sq. ft.** (Consolidated) | | **CAPEX Investment** | **₹46 crore** (Last 2 years) | **₹15 crore** (Ongoing expansion) | | **Production Capacity** | Scalable by **75-80%** via 2nd shift | **4x** current capacity upon completion | | **Quality Standards** | **AS9100D, ISO 9001, 14001, 45001** | Pursuing **NADCAP** (Aerospace) | | **Testing Capabilities** | **NABL-accredited** in-house lab | Specialized Medical/X-ray validation | --- ### **Financial Profile & Capital Efficiency** Following its **NSE SME IPO** in **October 2023** (which raised **₹45.16 crores** and was oversubscribed **91.65x**), the company has focused on "sweating assets" and deleveraging. **Key Financial Indicators:** * **Revenue (FY24 Actual):** **₹122.60 crores** (Projected **₹93.00 crores** for FY25 due to sector realignments). * **Profitability:** **EBITDA Margin** stood at **16.14%** in FY24; **PAT** for the same period was **₹11.30 crores**. * **Debt Reduction:** Long-term borrowings were reduced by **31.26%** post-IPO. * **Shareholder Value:** Standalone reserves reach **₹80.39 crores**; the company issued **4:1 bonus shares** in May 2023. * **Working Capital Target:** Management aims to free up **₹8-10 crore** of cash by **H1 FY26** through optimized inventory and payment terms. --- ### **Client Portfolio: Blue-Chip Partnerships** The company’s stability is underpinned by long-term relationships with global industry leaders: | Sector | Key Clients | | :--- | :--- | | **Healthcare** | Wipro GE Healthcare, Philips India, BPL Medical Technologies | | **Industrial & Elevators** | Atlas Copco, OTIS Elevator Company, Kirloskar Oil Engines | | **Energy & Oil** | GE India Industrial, GE Oil & Gas, GE Vernova | | **Transportation** | Wabtec India, Wabtec Transportation Systems, Mahindra & Mahindra | --- ### **Risk Factors & Mitigation Strategies** Management utilizes a formal **Risk Management Policy** overseen by the Audit Committee to navigate the following challenges: * **Client Reorganization:** The **GE spin-off** (April 2024) into three entities necessitated a realignment of order flows. **Mitigation:** Alignment with the new **GE Vernova** factory expected to be operational by **Sept 2025**. * **Long Qualification Cycles:** Aerospace and Defense contracts involve lengthy inspection and "first-article" approval processes. **Mitigation:** Diversification into **Mobility** and **Data Centers** to provide cash flow stability during long gestation periods. * **Sector Concentration:** Historically dependent on industrial automation. **Mitigation:** Rapid expansion into **EV** and **Aviation** to balance cyclicality. * **Regulatory Compliance:** Navigating evolving **CDSCO** and **AERB** norms for medical devices. **Mitigation:** Maintaining **NABL-accredited** testing facilities to ensure 100% compliance. --- ### **Future Outlook** Saakshi Medtech is positioned for a significant growth inflection point in **H2 FY26**. With a projected order pipeline of **₹2,250 crore** across all verticals and the consolidation of manufacturing into a high-capacity owned facility, the company is transitioning from a component supplier to a high-value systems integrator for the world’s most demanding industries.